| abstract |
The present invention relates to a novel peptide analogue, or a stereoisomer or pharmaceutically acceptable salt thereof, and more particularly to a novel peptide analogue, or a stereoisomer or a pharmaceutically acceptable salt thereof, which contains the novel peptide analogue or a stereoisomer or a pharmaceutically acceptable salt thereof as an active ingredient ≪ / RTI > The novel peptide analogue, or a stereoisomer or pharmaceutically acceptable salt thereof, is characterized in that it specifically binds to the poloxane domain of polo-like phosphorylase-1 and is characterized by inhibiting oocyte maturation, It can be utilized as a composition. |